20
Natco Pharma Limited Hyderabad In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Sumatriptan succinate, STS, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R0-CEP 2011-113 - Rev 02
This Chemical Type CEP, issued on February 14, 2017, remains in force until May 22, 2018, ensuring its reliability within the pharmaceutical industry.
Substance Number 1573 associated with this CEP further emphasizes